Rossari Biotech (India) Price Prediction
ROSSARI Stock | 793.45 8.50 1.08% |
Oversold Vs Overbought
59
Oversold | Overbought |
Quarterly Earnings Growth 0.072 | EPS Estimate Current Year 23.47 | EPS Estimate Next Year 28.8 | Wall Street Target Price 988.25 | Quarterly Revenue Growth 0.031 |
Using Rossari Biotech hype-based prediction, you can estimate the value of Rossari Biotech Limited from the perspective of Rossari Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Rossari Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying Rossari because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Rossari Biotech after-hype prediction price | INR 807.61 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Rossari |
Rossari Biotech After-Hype Price Prediction Density Analysis
As far as predicting the price of Rossari Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Rossari Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Rossari Biotech, with the unreliable approximations that try to describe financial returns.
Next price density |
Expected price to next headline |
Rossari Biotech Estimiated After-Hype Price Volatility
In the context of predicting Rossari Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Rossari Biotech's historical news coverage. Rossari Biotech's after-hype downside and upside margins for the prediction period are 714.11 and 809.67, respectively. We have considered Rossari Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Rossari Biotech is very steady at this time. Analysis and calculation of next after-hype price of Rossari Biotech is based on 3 months time horizon.
Rossari Biotech Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Rossari Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Rossari Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Rossari Biotech, there might be something going there, and it might present an excellent short sale opportunity.
Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.20 | 2.08 | 12.31 | 0.65 | 2 Events / Month | 1 Events / Month | In a few days |
Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
793.45 | 807.61 | 1.78 |
|
Rossari Biotech Hype Timeline
Rossari Biotech is at this time traded for 793.45on National Stock Exchange of India of India. The entity has historical hype elasticity of 12.31, and average elasticity to hype of competition of -0.65. Rossari is forecasted to increase in value after the next headline, with the price projected to jump to 807.61 or above. The average volatility of media hype impact on the company the price is about 3.38%. The price growth on the next news is projected to be 1.78%, whereas the daily expected return is at this time at -0.2%. The volatility of related hype on Rossari Biotech is about 63.93%, with the expected price after the next announcement by competition of 792.80. The company reported the revenue of 18.31 B. Net Income was 1.31 B with profit before overhead, payroll, taxes, and interest of 3.74 B. Assuming the 90 days trading horizon the next forecasted press release will be in a few days. Check out Rossari Biotech Basic Forecasting Models to cross-verify your projections.Rossari Biotech Related Hype Analysis
Having access to credible news sources related to Rossari Biotech's direct competition is more important than ever and may enhance your ability to predict Rossari Biotech's future price movements. Getting to know how Rossari Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Rossari Biotech may potentially react to the hype associated with one of its peers.
HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
GOKUL | Gokul Refoils and | (1.67) | 2 per month | 2.07 | 0.1 | 4.99 | (3.69) | 16.23 | |
SMLT | Sarthak Metals Limited | (2.91) | 2 per month | 0.00 | (0.02) | 5.30 | (5.42) | 22.92 | |
BFINVEST | BF Investment Limited | (10.55) | 3 per month | 2.60 | 0.03 | 5.20 | (4.74) | 17.29 | |
GMBREW | GM Breweries Limited | 0.00 | 0 per month | 0.00 | (0.12) | 3.44 | (4.73) | 12.09 | |
HISARMETAL | Hisar Metal Industries | (1.14) | 2 per month | 2.06 | 0.07 | 4.86 | (4.01) | 15.13 | |
VBL | Varun Beverages Limited | (3.25) | 4 per month | 0.00 | (0.04) | 3.36 | (3.09) | 12.12 |
Rossari Biotech Additional Predictive Modules
Most predictive techniques to examine Rossari price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Rossari using various technical indicators. When you analyze Rossari charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
About Rossari Biotech Predictive Indicators
The successful prediction of Rossari Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Rossari Biotech Limited, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Rossari Biotech based on analysis of Rossari Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Rossari Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Rossari Biotech's related companies.
Story Coverage note for Rossari Biotech
The number of cover stories for Rossari Biotech depends on current market conditions and Rossari Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Rossari Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Rossari Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Rossari Biotech Short Properties
Rossari Biotech's future price predictability will typically decrease when Rossari Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Rossari Biotech Limited often depends not only on the future outlook of the potential Rossari Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Rossari Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding | 55.3 M | |
Cash And Short Term Investments | 667.9 M |
Complementary Tools for Rossari Stock analysis
When running Rossari Biotech's price analysis, check to measure Rossari Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rossari Biotech is operating at the current time. Most of Rossari Biotech's value examination focuses on studying past and present price action to predict the probability of Rossari Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rossari Biotech's price. Additionally, you may evaluate how the addition of Rossari Biotech to your portfolios can decrease your overall portfolio volatility.
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |